Downregulation of the ornithine decarboxylase/polyamine system inhibits angiotensin-induced hypertrophy of cardiomyocytes through the NO/cGMP-dependent Protein kinase type-i pathway

Cellular Physiology and Biochemistry

Volumn 25, Issue 4-5, 2010, Pages 443-450

  Lin, Yan ^a,b   Liu, Ji Cheng ^a   Zhang, Xiao Jie ^a   Li, Guang Wei ^a,b   Wang, Li Na ^b   Xi, Yu Hui ^b   Li, Hong Zhu ^b   Zhao, Ya Jun ^b   Xu, Chang Qing ^b,c  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c Biopharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

Cardiomyocyte; Hypertrophy; NO; Polyamines

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CALCIUM; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE TYPE I; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; MYC PROTEIN; NITRIC OXIDE; ORNITHINE DECARBOXYLASE; PHALLOIDIN; POLYAMINE; PROTEIN C FOS; PUTRESCINE; SPERMIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

EID: 77949984999     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000303049     Document Type: Article

References (29)

1. Mann DL: Mechanisms and models in heart failure: A combinatorial approach. Circulation 1999;100:999-1008.
2. Hunter JJ, Chien KR: Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999;341:1276-1283.
3. Molkentin JD, Dorn GW 2nd: Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001;63:391-426.
4. Frey N, McKinsey TA, Olson EN: Decoding calcium signals involved in cardiac growth and function. Nat Med 2000;6:1221-1227.
5. Bueno OF, Molkentin JD: Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 2002;91:776-781.
6. Chen QM, Tu VC, Purdon S, Wood J, Dilley T: Molecular mechanisms of cardiac hypertrophy induced by toxicants. Cardiovasc Toxicol 2001;1:267-283.
7. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P: Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 2001;98:74202-74208
8. Salvi M, Toninello A: Effects of polyamines on mitochondrial Ca2+ transport. Biochim Biophys Acta 2004;1661:113-124.
9. Lin Y, Wang LN, Xi YH, Li HZ, Xiao FG, Zhao YJ, Tian Y, Yang BF, Xu CQ: L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways. Basic Clin Pharmacol Toxicol 2008; 103:124-130.
10. Wallace JL, Ignarro LJ, Fiorucci S: Potential cardioprotective actions of no-releasing aspirin. Nat Rev Drug Discov 2002;5:375-382.
11. Mühling J, Engel J, Halabi M, Müller M, Fuchs M, Krüll M, Harbach H, Langefeld TW, Wolff M, Matejec R, Welters ID, Menges T, Hempelmann G: Nitric oxide and polyamine pathways-dependent modulation of neutrophil free amino-and α-keto acide profiles or host defense capability. Amino Acids 2006; 31:11-26.
12. Thorburn J, Frost JA, Thorburn A: Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J Cell Biol 1994;126:1565-1572.
13. Manni A, Washington S, Griffith JW, Verderame MF, Mauger D, Demers LM, Samant RS, Welch DR: Influence of polyamines on in vitro and in vivo features of aggressive+and metastatic behavior by human breast cancer cells. Clin Exp Metastasis 2002;19:95-105.
14. Maiti S, Chen X, Chen G. All-trans retinoic acid induction of sulfotransferases. Basic Clin Pharmacol Toxicol 2005;96:44-53.
15. Xu C, Lu Y, Tang G, Wang R: Expression of voltage-dependent K(+) channel genes in mesenteric artery smooth muscle cells. Am J Physiol 1999; 277:G1055-1063.
16. Cheng TH, Shih NL, Chen S Y, Lin JW, Chen YL, Chen CH, Lin H, Cheng CF, Chiu WT, Wang DL, Chen JJ: Nitric oxide inhibits endothelin-1-induced cardiomyocyte hypertrophy through cGMP-mediated suppression of extracellular-signal regulated kinase phosphorylation. Mol Pharmacol 2005;68:1183-1192.
17. Ibrahim J, Schachter M, Hughes AD, Sever PS: Role of polyamines in hypertension induced by angiotensin II. Cardiovasc Res 1995;29:50-56.
18. Lipke DW, Newman PS, Tofiq S, Guo H, Arcot SS, Aziz SM, Olson JW, Soltis EE: Multiple polyamine regulatory pathways control compensatory cardiovascular hypertrophy in coarctation hypertension. Clin Exp Hypertens 1997;19:269-295.
19. Shantz LM, Feith DJ, Pegg AE: Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy. Biochem J 2001;358:25-32.
20. Paulus WJ, Bronzwaer JG: Nitric oxide's role in the heart: control of beating or breathing? Am J Physiol 2004;287:H8-H13.
21. Komuro I, Yazaki Y: Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 1993;55:55-75.
22. Sadoshima J, Izumo S: The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 1997;59:551-571.
23. Sadoshima J, Izumo S: Molecular characterization of angiotensinII-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res 1993;73:413-423.
24. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 1988; 48:759-774.
25. Ray RM, Zimmerman BJ, McCormack SA, Patel TB, Johnson LR: Polyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells. Am J Physiol 1999;276:C684-691.
26. Fiedler B, Lohmann SM, Smolenski A, Linnemuller S, Pieske B, Schroder F, Molkentin JD, Drexler H, Wollert KC: Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci USA 2002;99:11363-11368.
27. Wegener JW, Nawrath H, Wolfsgruber W, Kühbandner S, Werner C, Hofmann F, Feil R: cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium. Circ Res 2002;90:18-20.
28. 2+ channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice. Cardiovasc Res 2003;60:268-277.
29. Parameswaran N, Hall CS, McCabe LR, Spielman WS: Adrenomedullin increases AP-1 expression in rat mesangial cells via activation of protein kinase-A and p38 MAPK. Cell Physiol Biochem 2003;13:367-374.